SBWire (press release) Unfortunately, the drug , which is classified as a thiazolidinedione , or TZD medication , has had its first two releases pulled from the market due to some extremely serious side effects involving the cardiovascular system. Recently, Actos was identified ...
Family Practice News Digital Network Available data on a possible link between antihyperglycemic drugs and an increased risk of pancreatitis and certain cancers do not justify making changes in clinical practice, according to a consensus statement on diabetes and cancer released by the ... and more »
BioNews Texas The research team studied the properties and activities of popular hypoglycemic medication rosiglitazone (categorized under the hypoglycemic class- thiazolidinedione ), which is associated with increasing the risk of cardiovascular issues. However, the ...
Family Practice News Digital Network Available data on a possible link between antihyperglycemic drugs and an increased risk of pancreatitis and certain cancers do not justify making changes in clinical practice, according to a consensus statement on diabetes and cancer released by the ... and more »
Phys.Org Hope comes in the form of a controversial drug , rosiglitazone, in the thiazolidinedione class of medications used in diabetes treatment, he said. The drug is suspected of causing heart problems over long-term use by diabetes patients. But tests on ... and more »
R & D Magazine Hope comes in the form of a controversial drug , rosiglitazone, in the thiazolidinedione class of medications used in diabetes treatment, he said. The drug is suspected of causing heart problems over long-term use by diabetes patients. But tests on ...
Family Practice News Digital Network Available data on a possible link between antihyperglycemic drugs and an increased risk of pancreatitis and certain cancers do not justify making changes in clinical practice, according to a consensus statement on diabetes and cancer released by the ... and more »
Family Practice News Digital Network Available data on a possible link between antihyperglycemic drugs and an increased risk of pancreatitis and certain cancers do not justify making changes in clinical practice, according to a consensus statement on diabetes and cancer released by the ... and more »
Family Practice News Digital Network Available data on a possible link between antihyperglycemic drugs and an increased risk of pancreatitis and certain cancers do not justify making changes in clinical practice, according to a consensus statement on diabetes and cancer released by the ... and more »
